Grow Your Wealth
with Mutual Funds
Mirae Asset Healthcare Fund Regular-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 2,753.7 Cr.
NAV as on 27 jul, 2026
₹ 44.82
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Mirae Asset Healthcare Fund Regular-growth
Inception Date
02 Jul 2018
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
99.78%
Debt
0.01%
Cash
0.22%
Portfolio Updated on: 13 Jul, 2026
Sector Allocations
Equity
Healthcare
Materials
Industrials
Portfolio Updated on: 27 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.06% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.44% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.01% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.01% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.20% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.77% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.11% |
Debt & Credit Risk Analysis
| Alpha | -0.71% |
| Beta | 0.97% |
| Sharpe Ratio | 0.99% |
| Standard Deviation | 16.73% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 11.29% | NA | 6.12% |
| 6 Months | 23.75% | NA | 12.92% |
| 9 Months | 15.31% | NA | 4.47% |
| 1 Year | 12.93% | 12.93% | 6.04% |
| 2 Years | 25.40% | 11.98% | 24.93% |
| 3 Years | 79.72% | 21.58% | 25.71% |
| 5 Years | 96.46% | 14.46% | 19.91% |
| 7 Years | 342.19% | 23.66% | NA |
Mirae Asset Healthcare Fund Regular-growth is one Equity mutual fund offered by Mirae Asset Mutual Fund. Launched on 02 Jul 2018, the fund aims To generate long term capital appreciation. Investments in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. It manages assets worth ₹2,753.7 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.94%.
Tanmay Mehta has experience Prior to joining the Mirae asset MF, he was associated with SBI capital markets.
Vrijesh Kasera has experience Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Mirae Asset Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Mirae Asset Healthcare Fund Direct-growth | 2,753.7 | +4.50% | +11.69% | +24.64% | +14.57% | +23.36% | +16.17% |
| Mirae Asset Healthcare Fund Regular-idcw | 2,753.7 | +4.37% | +11.29% | +23.75% | +12.93% | +21.58% | +14.46% |
| Mirae Asset Healthcare Fund Direct-idcw | 2,753.7 | +4.50% | +11.69% | +24.64% | +14.57% | +23.36% | +16.17% |
| Mirae Asset Nifty 500 Healthcare Etf-growth | 7.6 | +3.31% | +11.84% | — | — | — | — |
| Mirae Asset Nifty 500 Healthcare Etf-growth | 7.6 | +3.31% | +11.84% | — | — | — | — |
| Mirae Asset Nifty 500 Healthcare Etf-growth | 7.6 | +3.31% | +11.84% | — | — | — | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.15 | +24.11% | +17.02% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.47 | +24.11% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹506.05 | +22.55% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹318.78 | +22.55% | +17.02% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹50.72 | +23.36% | +16.17% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹30.55 | +23.36% | +16.17% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 27 Jul 2026 | ₹44.82 |
| 24 Jul 2026 | ₹44.14 |
| 23 Jul 2026 | ₹44.20 |
| 22 Jul 2026 | ₹44.44 |
| 21 Jul 2026 | ₹44.95 |
| 20 Jul 2026 | ₹44.86 |
| 17 Jul 2026 | ₹44.38 |
| 16 Jul 2026 | ₹44.83 |
| 15 Jul 2026 | ₹44.87 |
| 14 Jul 2026 | ₹44.72 |
| 13 Jul 2026 | ₹44.40 |
| 10 Jul 2026 | ₹44.32 |
| 09 Jul 2026 | ₹44.19 |
| 08 Jul 2026 | ₹43.70 |
| 07 Jul 2026 | ₹44.17 |
| 06 Jul 2026 | ₹44.43 |
| 03 Jul 2026 | ₹44.33 |
| 02 Jul 2026 | ₹43.74 |
| 01 Jul 2026 | ₹43.38 |
| 30 Jun 2026 | ₹43.59 |
| 29 Jun 2026 | ₹43.25 |
| 25 Jun 2026 | ₹42.95 |
| 24 Jun 2026 | ₹42.97 |
| 23 Jun 2026 | ₹42.95 |
| 22 Jun 2026 | ₹42.74 |
| 19 Jun 2026 | ₹42.54 |
| 18 Jun 2026 | ₹42.19 |
| 17 Jun 2026 | ₹41.82 |
| 15 Jun 2026 | ₹41.95 |
| 12 Jun 2026 | ₹42.27 |
Portfolio Updated on: 28 Jul, 2026
Fund Growth & Size Analysis
+₹2,753.7 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Mirae Asset Healthcare Fund Regular-growth Returns Comparison
Compare Mirae Asset Healthcare Fund Regular-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Mirae Asset Healthcare....
No funds found for your search.
Mirae Asset Healthcare Fund Regular-growth FAQ'S
- Sharpe Ratio: 0.99%
- Standard Deviation: 16.73%
- Beta: 0.97%
- Alpha: -0.71%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under Mirae Asset Healthcare Fund Regular-growth stand at approximately ₹ 2,753.7 crore.
The Mirae Asset Healthcare Fund Regular-growth has delivered the following short-term performance:
- 3 Months Return: 11.29%
- 6 Months Return: 23.75%
The historical growth of the Mirae Asset Healthcare Fund Regular-growth is reflected through its CAGR returns:
- 3 Year CAGR: 21.58%
- 5 Year CAGR: 14.46%
- Return Since Launch: 20.42%
The portfolio of Mirae Asset Healthcare Fund Regular-growth is distributed across different asset classes as follows:
- Equity: 99.78%
- Debt Instruments: 0.01%
- Other Assets: 0.22%
The Mirae Asset Healthcare Fund Regular-growth is managed by Vrijesh Kasera, representing Mirae Asset Mutual Fund.
The Mirae Asset Healthcare Fund Regular-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of Mirae Asset Healthcare Fund Regular-growth include:
- Sun Pharmaceutical Industries Ltd – represents 13.06% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.44% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.01% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.01% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.20% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.77% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.11% of the portfolio
Major sector exposures in Mirae Asset Healthcare Fund Regular-growth are:
- Healthcare – accounts for 950.03% of the portfolio
- Materials – accounts for 16.51% of the portfolio
- Industrials – accounts for 5.62% of the portfolio
